PATHWAYS platform expands with growth of the VQI
American Venous Forum and Society for Vascular Surgery Launch Expanded Quality Initiative
West Lebanon, NH Jan 10, 2013 – The Society for Vascular Surgery® (SVS) and the American Venous Forum (AVF) are pleased to announce the expansion of the SVS Vascular Quality Initiative®(VQI) to include the treatment of venous disease. The VQI, launched by SVS in 2011, will now include both arterial and venous procedures. Data collection and analysis tools for the VQI are provided through M2S’s PATHWAYS cloud-based clinical data performance platform.
“This expansion of the VQI enhances SVS’ mission to assist its members in understanding and improving patient outcomes by encouraging the collection, aggregation, and analysis of clinical data,” said Peter Gloviczki, MD, SVS president. “As more than 20 percent of the adult population suffers from chronic venous diseases, AVF is committed to expanding its efforts through the VQI to assess the efficacy of various treatments for patients with venous disease,” according to AVF president Robert McLafferty, MD.
The partnership with M2S positions AVF and SVS as leaders in vascular quality improvement by providing a platform for their members to analyze outcomes, determine best practices, and collaborate on quality improvement efforts across regions. Currently, the VQI has more than 200 participating centers across the United States and Canada. Regional quality groups have been established throughout the United States to share and analyze the data collected by individual sites and to initiate local quality improvement projects that affect patient care.
“M2S has a long history of managing healthcare information for the purpose of improving patient care. We are excited to partner with AVF and SVS to broaden our impact on healthcare quality improvement and clinical outcomes and to ensure the continued success of the VQI through our PATHWAYS platform. We have designed PATHWAYS to meet the critical challenges in healthcare and empower physicians to analyze individual procedure outcomes along with their peers,” said Greg Lange, president and chief executive officer of M2S.